Small molecule biomarkers predictive of Chagas disease progression
Liu, Z.; Vucetich, S.; DeToy, K.; Duran Saucedo, G.; Verastegui, M.; Carballo-Jimenez, P.; Mercado-Saavedra, B. N.; Tinajeros, F.; Malaga-Machaca, E. S.; Marcus, R.; Gilman, R. H.; Bowman, N. M.; McCall, L.-I.
Show abstract
Chagas disease (CD) is a neglected tropical disease caused by the parasitic protozoan Trypanosoma cruzi. However, only 20% to 30% of infected individuals will progress to severe symptomatic cardiac manifestations. Current treatments are benznidazole and nifurtimox, which are poorly tolerated regimens. Developing a biomarker to determine the likelihood of patient progression would be helpful for doctors to optimize patient treatment strategies. Such a biomarker would also benefit drug discovery efforts and clinical trials. In this study, we combined untargeted and targeted metabolomics to compare serum samples from T. cruzi-infected individuals who progressed to severe cardiac disease, versus infected individuals who remained at the same disease stage (non-progressors). We identified four unannotated biomarker candidates, which were validated in an independent cohort using both untargeted and targeted analysis techniques. Overall, our findings demonstrate that serum small molecules can predict CD progression, offering potential for clinical monitoring.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tuberculosis causes highly conserved metabolic changes in human patients, mycobacteria-infected mice and zebrafish larvae 96%
- Small-molecule metabolome identifies potential therapeutic targets against COVID-19 94%
- Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition 93%
Similar papers in this journal
- Albumin-dependent and independent mechanisms in the syndrome of kwashiorkor 92%
- Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms 91%
- Cold exposure induces dynamic changes in circulating triacylglycerol species, which is dependent on intracellular lipolysis: a randomized cross-over trial 91%
Similar papers in this journal
- Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas disease 95%
- Conjugates of α-d-Galp-(1->3)-β-d-Galp for the serological diagnosis of Chagas disease. 92%
- Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections 91%
Similar papers in this journal
- Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity 94%
- Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury 94%
- Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection 91%
Similar papers in this journal
- A distinct metabolic profile associated with a fatal outcome in COVID-19 patients during early epidemic in Italy 92%
- Tryptophan and arginine metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis 92%
- Prospective Fecal Microbiomics Biomarkers for Chronic Wasting Disease 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.